Literature DB >> 32029545

Accuracy of a machine learning muscle MRI-based tool for the diagnosis of muscular dystrophies.

José Verdú-Díaz1, Jorge Alonso-Pérez1, Claudia Nuñez-Peralta1, Giorgio Tasca1, John Vissing1, Volker Straub1, Roberto Fernández-Torrón1, Jaume Llauger1, Isabel Illa1, Jordi Díaz-Manera2.   

Abstract

OBJECTIVE: Genetic diagnosis of muscular dystrophies (MDs) has classically been guided by clinical presentation, muscle biopsy, and muscle MRI data. Muscle MRI suggests diagnosis based on the pattern of muscle fatty replacement. However, patterns overlap between different disorders and knowledge about disease-specific patterns is limited. Our aim was to develop a software-based tool that can recognize muscle MRI patterns and thus aid diagnosis of MDs.
METHODS: We collected 976 pelvic and lower limbs T1-weighted muscle MRIs from 10 different MDs. Fatty replacement was quantified using Mercuri score and files containing the numeric data were generated. Random forest supervised machine learning was applied to develop a model useful to identify the correct diagnosis. Two thousand different models were generated and the one with highest accuracy was selected. A new set of 20 MRIs was used to test the accuracy of the model, and the results were compared with diagnoses proposed by 4 specialists in the field.
RESULTS: A total of 976 lower limbs MRIs from 10 different MDs were used. The best model obtained had 95.7% accuracy, with 92.1% sensitivity and 99.4% specificity. When compared with experts on the field, the diagnostic accuracy of the model generated was significantly higher in a new set of 20 MRIs.
CONCLUSION: Machine learning can help doctors in the diagnosis of muscle dystrophies by analyzing patterns of muscle fatty replacement in muscle MRI. This tool can be helpful in daily clinics and in the interpretation of the results of next-generation sequencing tests. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that a muscle MRI-based artificial intelligence tool accurately diagnoses muscular dystrophies.
© 2020 American Academy of Neurology.

Entities:  

Mesh:

Year:  2020        PMID: 32029545     DOI: 10.1212/WNL.0000000000009068

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

Review 1.  MR imaging of inherited myopathies: a review and proposal of imaging algorithms.

Authors:  Laís Uyeda Aivazoglou; Julio Brandão Guimarães; Thomas M Link; Maria Alice Freitas Costa; Fabiano Nassar Cardoso; Bruno de Mattos Lombardi Badia; Igor Braga Farias; Wladimir Bocca Vieira de Rezende Pinto; Paulo Victor Sgobbi de Souza; Acary Souza Bulle Oliveira; Alzira Alves de Siqueira Carvalho; André Yui Aihara; Artur da Rocha Corrêa Fernandes
Journal:  Eur Radiol       Date:  2021-04-21       Impact factor: 5.315

2.  Diagnostic magnetic resonance imaging biomarkers for facioscapulohumeral muscular dystrophy identified by machine learning.

Authors:  Mauro Monforte; Sara Bortolani; Eleonora Torchia; Lara Cristiano; Francesco Laschena; Tommaso Tartaglione; Enzo Ricci; Giorgio Tasca
Journal:  J Neurol       Date:  2021-09-06       Impact factor: 4.849

3.  Structured bone marrow report as an assessment tool in patients with hematopoietic disorders.

Authors:  Mercedes Roca-Espiau; Esther Valero-Tena; Maria Jose Ereño-Ealo; Pilar Giraldo
Journal:  Quant Imaging Med Surg       Date:  2022-07

4.  Random forest: random results or meaningful insights for patients with facioscapulohumeral muscular dystrophy?

Authors:  Lindsay N Alfano; Tahseen Mozaffar
Journal:  Brain       Date:  2021-12-16       Impact factor: 15.255

5.  Global versus individual muscle segmentation to assess quantitative MRI-based fat fraction changes in neuromuscular diseases.

Authors:  Harmen Reyngoudt; Benjamin Marty; Jean-Marc Boisserie; Julien Le Louër; Cedi Koumako; Pierre-Yves Baudin; Brenda Wong; Tanya Stojkovic; Anthony Béhin; Teresa Gidaro; Yves Allenbach; Olivier Benveniste; Laurent Servais; Pierre G Carlier
Journal:  Eur Radiol       Date:  2020-11-21       Impact factor: 5.315

6.  Muscle MRI characteristic pattern for late-onset TK2 deficiency diagnosis.

Authors:  Cristina Domínguez-González; Roberto Fernández-Torrón; Ursula Moore; Carlos Pablo de Fuenmayor-Fernández de la Hoz; Beatriz Vélez-Gómez; Juan Antonio Cabezas; Jorge Alonso-Pérez; Laura González-Mera; Montse Olivé; Jorge García-García; Germán Moris; Juan Carlos León Hernández; Nuria Muelas; Emilia Servian-Morilla; Miguel A Martin; Jordi Díaz-Manera; Carmen Paradas
Journal:  J Neurol       Date:  2022-03-14       Impact factor: 6.682

7.  The value of qualitative muscle MRI in the diagnostic procedures of myopathies: a biopsy-controlled study in 191 patients.

Authors:  Diana Lehmann Urban; Mohamed Mohamed; Albert C Ludolph; Jan Kassubek; Angela Rosenbohm
Journal:  Ther Adv Neurol Disord       Date:  2021-02-26       Impact factor: 6.570

Review 8.  Overview of MR Image Segmentation Strategies in Neuromuscular Disorders.

Authors:  Augustin C Ogier; Marc-Adrien Hostin; Marc-Emmanuel Bellemare; David Bendahan
Journal:  Front Neurol       Date:  2021-03-25       Impact factor: 4.003

9.  The expanding role of MRI in neuromuscular disorders.

Authors:  Pierre G Carlier; Harmen Reyngoudt
Journal:  Nat Rev Neurol       Date:  2020-06       Impact factor: 42.937

10.  Plasma lipidomic analysis shows a disease progression signature in mdx mice.

Authors:  Roula Tsonaka; Alexandre Seyer; Annemieke Aartsma-Rus; Pietro Spitali
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.